According to an article in Science Daily, a class of drugs may help improve learning and cognition in people with Fragile X Syndrome. "The researchers have found that a class of drugs called phosphoinositide-3 (PI3) kinase inhibitors can correct defects in the anatomy of neurons seen in a mouse model of fragile X syndrome. The drugs can potentially restore normal appearance and levels of protein production at synapses, the junctions between cells where chemical communication occurs, resulting in improved learning and cognition.
To read the entire article, go to: http://www.sciencedaily.com/releases/2010/08/100810203501.htm
No comments:
Post a Comment